Patents Assigned to Roche Sequencing Solutions, Inc.
-
Patent number: 11754549Abstract: Devices for sequencing linear biomolecules (e.g., DNA, RNA, polypeptides, proteins, and the like) using quantum tunneling effects, and methods of making and using such devices, are provided. A nanofabricated device can include a small gap formed by depositing a thin film between two electrodes, and subsequently removing the film using an etching process. The width of the resulting gap can correspond with the size of a linear biomolecule such that when a part of the biomolecule (e.g., a nucleobase or amino acid) is present in the gap, a change in tunneling current, voltage, or impedance can be measured and the part of the biomolecule identified. The gap dimensions can be precisely controlled at the atomic-scale by, for example, atomic layer deposition (ALD) of the sacrificial film. The device can be made using existing integrated circuit fabrication equipment and facilities, and multiple devices can be formed on a single chip.Type: GrantFiled: June 13, 2022Date of Patent: September 12, 2023Assignee: Roche Sequencing Solutions, Inc.Inventor: Steven Henck
-
Patent number: 11746337Abstract: Disclosed are methods for isolating polymerase complexes from a mixture of polymerase complex components. The polymerase complexes can comprise a nanopore to provide isolated nanopore sequencing complexes. The methods relate to the positive and negative isolation of the polymerase complexes and/or nanopore sequencing complexes. Also disclosed is a nucleic acid adaptor for isolating active polymerase complexes, polymerase complexes comprising the nucleic acid adaptor, and methods for isolating active polymerase complexes using the nucleic acid adaptor.Type: GrantFiled: May 11, 2020Date of Patent: September 5, 2023Assignee: Roche Sequencing Solutions, Inc.Inventors: Helen Franklin, Cynthia Cech, Timothy Kellogg Craig, Aruna Ayer, Kirti Dhiman, Natalie B. Chechelski Johnston, Joshua N. Mabry, Arkadiusz Bibillo, Peter Crisalli, Randall W. Davis
-
Publication number: 20230273199Abstract: Disclosed herein are devices, systems, and methods for monitoring single-molecule biological processes using magnetic sensors and magnetic particles (MNP). A MNP is attached to a biopolymer (e.g., a nucleic acid, protein, etc.), and motion of the MNP is detected and/or monitored using a magnetic sensor. Because the MNP is small (e.g., its size is comparable to the size of the molecule being monitored) and is tethered to a biopolymer, changes in the volume of Brownian motion of the MNP in a solution can be monitored to monitor the movement of the MNP and, by inference, the tethered biopolymer. The magnetic sensor is small (e.g., nanoscale or having a size on the order of the sizes of the MNP and the biopolymer) and can be used to detect even small changes in the position of the MNP within the sensing region of the magnetic sensor.Type: ApplicationFiled: July 8, 2021Publication date: August 31, 2023Applicants: Roche Sequencing Solutions, Inc., Western Digital Technologies, Inc.Inventors: Juraj TOPOLANCIK, Patrick BRAGANCA, Seong-Ho SHIN, Yann ASTIER, Zsolt MAJZIK
-
Patent number: 11739378Abstract: The present disclosure relates to compositions and methods based on polypeptide-tagged nucleotide, and the use of such polypeptide-tagged nucleotides in nanopore devices and methods.Type: GrantFiled: March 15, 2021Date of Patent: August 29, 2023Assignees: Roche Sequencing Solutions, Inc., Roche Molecular Systems, Inc.Inventors: Frank Bergmann, Christoph Seidel, Andrew Trans, Dmitriy Gremyachinskiy, Hannes Kuchelmeister, Lars Hillringhaus
-
Patent number: 11740227Abstract: A nanopore cell includes a conductive layer and a working electrode disposed above the conductive layer and at the bottom of a well into which an electrolyte may be contained, such that at least a portion of a top base surface area of the working electrode is exposed to the electrolyte. The nanopore cell further includes a first insulating wall disposed above the working electrode and surrounding a lower section of a well, and a second insulating wall disposed above the first insulating wall and surrounding an upper section of the well, forming an overhang above the lower section of the well. The upper section of the well includes an opening that a membrane may span across, and wherein a base surface area of the opening is smaller than the at least a portion of the top base surface area of the working electrode that is exposed to the electrolyte.Type: GrantFiled: May 27, 2022Date of Patent: August 29, 2023Assignee: Roche Sequencing Solutions, Inc.Inventors: John Foster, Morgan Mager
-
Patent number: 11739380Abstract: A method of analyzing a molecule is disclosed. A lipid bilayer is formed such that it divides a first reservoir characterized by a first reservoir osmolarity from a second reservoir characterized by a second reservoir osmolarity. An electrolyte solution is flowed to the first reservoir that tends to make a first change to a ratio of the first reservoir osmolarity to the second reservoir osmolarity. A voltage is applied across the lipid bilayer, wherein the lipid bilayer is inserted with a nanopore, and wherein a net transfer of ions between the first reservoir and the second reservoir tends to make a second change to the ratio of the first reservoir osmolarity to the second reservoir osmolarity, and wherein the first change to the ratio and the second change to the ratio tends to counter-balance each other.Type: GrantFiled: March 12, 2021Date of Patent: August 29, 2023Assignee: Roche Sequencing Solutions, Inc.Inventors: Geoffrey Barrall, Jason Komadina, Marcin Rojek
-
Patent number: 11732290Abstract: The invention provides methods, compositions, kits and devices for the detection of target molecules. In some embodiments, the invention allows for multiplexed target molecule detection.Type: GrantFiled: September 22, 2022Date of Patent: August 22, 2023Assignee: ROCHE SEQUENCING SOLUTIONS, INC.Inventor: Garry P. Nolan
-
Patent number: 11725229Abstract: A method of detecting a state of a lipid membrane in a cell of a nanopore based sequencing chip is disclosed. A lipid membrane is coupled with an integrating capacitor, wherein the lipid membrane is between a working electrode and a counter electrode. An alternating current (AC) voltage is applied to the counter electrode. A voltage across the integrating capacitor is periodically sampled by an analog-to-digital converter (ADC). A change in the sampled voltage across the integrating capacitor in response to an intermediate change in the AC voltage is determined. A state of the lipid membrane is determined based on the determined change in the sampled voltage across the integrating capacitor in response to the intermediate change in the AC voltage.Type: GrantFiled: April 7, 2020Date of Patent: August 15, 2023Assignee: Roche Sequencing Solutions, Inc.Inventor: Ashraf Wahba
-
Patent number: 11726059Abstract: Embodiments of the present technology may allow for the analysis of molecules by tunneling recognition at a tunneling junction. A tunneling junction of the present technology can include an insulating layer between two electrodes. A voltage may be applied to the electrodes. When a molecule makes contact with both electrodes, the molecule allows current to tunnel through the molecule. The characteristics of the current may aid in identifying a portion of the molecule, for example, a particular nucleotide or base present in a nucleic acid molecule. Methods and systems for analysis of molecules are described.Type: GrantFiled: September 30, 2021Date of Patent: August 15, 2023Assignee: Roche Sequencing Solutions, Inc.Inventors: Yann Astier, Juraj Topolancik
-
Patent number: 11725307Abstract: Methods and compositions are described herein for primer extension target enrichment of immune receptor (BCR or TCR) sequences.Type: GrantFiled: May 4, 2021Date of Patent: August 15, 2023Assignee: Roche Sequencing Solutions, Inc.Inventors: Jan Berka, Brian Godwin, Carolina Dallett, Sedide Ozturk, Joseph Platzer, Seoyoung Kim
-
Patent number: 11718836Abstract: Described herein are polymerase variants that are exonuclease deficient. Some variants retain the strand displacement capability comparable to the wild-type or parental polymerase. Some variants have a strand displacement capability that is improved relative to the wild-type or parental polymerase. The variants may have an extension rate that is greater than the wild-type or parental polymerase. The variants may have a waiting time that is less than the wild-type or parental polymerase.Type: GrantFiled: February 5, 2021Date of Patent: August 8, 2023Assignee: Roche Sequencing Solutions, Inc.Inventors: Aruna Ayer, Arkadiusz Bibillo, Preethi Sarvabhowman, Dhruti Vasudev Dalal, Ilya Lederman, Eileen Thai
-
Patent number: 11718870Abstract: Molecules may be analyzed (e.g., sequencing of nucleic acid molecules) by tunneling recognition at a tunneling junction. Embodiments of the present invention may allow detecting individual nucleotides and the sequencing of a nucleic acid molecule using a tunneling junction. By labeling a specific nucleotide with a moiety, tunneling junctions may generate a signal with a suitable signal-to-noise ratio. The tunneling recognition uses a tunneling current that is mostly through the moiety rather than mostly through the nucleotide or a portion of the molecule of interest. Because a single nucleotide can be detected with a signal with a suitable signal-to-noise ratio resulting from the tunneling current passing through the moiety, embodiments of the present invention may allow for fast detection of nucleotides using a tunneling current.Type: GrantFiled: June 19, 2019Date of Patent: August 8, 2023Assignee: Roche Sequencing Solutions, Inc.Inventors: Yann Astier, Juraj Topolancik, Hannes Kuchelmeister, Frank Bergmann, Dieter Heindl, Nikolaus Klaus-Peter Stengele
-
Patent number: 11708599Abstract: The invention provides methods, compositions, kits and devices for the detection of target molecules. In some embodiments, the invention allows for multiplexed target molecule detection.Type: GrantFiled: December 21, 2022Date of Patent: July 25, 2023Assignee: ROCHE SEQUENCING SOLUTIONS, INC.Inventor: Garry P. Nolan
-
Patent number: 11702697Abstract: The present invention provides method essentially comprising the steps of (i) providing a DNA sample, (ii) providing at least a first pair of amplification primers which is capable of generating a first amplicon from a LINE sequence that has a size of less than 80 bp, (iii) providing at least a second pair of amplification primers which is capable of generating a second amplicon from a LINE sequence that has a size of more than 160 bp, (iv) performing a qPCR and determining cq values for each of the generated amplicons, and (v) determining the relative concentrations of said amplicons.Type: GrantFiled: May 14, 2018Date of Patent: July 18, 2023Assignee: Roche Sequencing Solutions, Inc.Inventors: Sophie Beckert, Bernd Hinzmann
-
Patent number: 11692214Abstract: The invention provides methods, compositions, kits and devices for the detection of target molecules. In some embodiments, the invention allows for multiplexed target molecule detection.Type: GrantFiled: December 21, 2022Date of Patent: July 4, 2023Assignee: ROCHE SEQUENCING SOLUTIONS, INC.Inventor: Garry P. Nolan
-
Patent number: 11691141Abstract: The present disclosure generally relates to devices for effecting epitachophoresis. Epitachophoresis may be used to effect sample analysis, such as by selective separation, detection, extraction, and/or pre-concentration of target analytes such as, for example, DNA, RNA, and/or other biological molecules. Said target analytes may be collected following epitachophoresis and used for desired downstream applications and further analysis.Type: GrantFiled: November 13, 2018Date of Patent: July 4, 2023Assignee: Roche Sequencing Solutions, Inc.Inventors: Yann Astier, Jan Berka, Ulrich Schlecht, Frantisek Foret, Vladimira Datinska, Ivona Voracova
-
Patent number: 11686706Abstract: A nanopore based sequencing system includes a plurality of nanopore sensors. Each nanopore sensor has a portion for receiving a fluid. The nanopore based sequencing system includes a fluid chamber configured to guide the fluid over the plurality of nanopore sensors and an inlet configured to deliver the fluid into the fluid chamber. At least a portion of the fluid chamber is made of a material that has been molded around at least a portion of an electrode.Type: GrantFiled: July 15, 2020Date of Patent: June 27, 2023Assignee: Roche Sequencing Solutions, Inc.Inventors: Edward Liu, Kenneth M. Stothers, Markus Wallgren, Janusz B. Wojtowicz, Robert A. Yuan
-
Patent number: D996642Type: GrantFiled: February 13, 2023Date of Patent: August 22, 2023Assignee: Roche Sequencing Solutions, Inc.Inventors: Frantisek Foret, Ivona Voracova, Jan Prikryl, Jakub Novotny
-
Patent number: D996643Type: GrantFiled: February 13, 2023Date of Patent: August 22, 2023Assignee: Roche Sequencing Solutions, Inc.Inventors: Frantisek Foret, Ivona Voracova, Jan Prikryl, Jakub Novotny
-
Patent number: D997384Type: GrantFiled: February 13, 2023Date of Patent: August 29, 2023Assignee: Roche Sequencing Solutions, Inc.Inventors: Frantisek Foret, Ivona Voracova, Jan Prikryl, Jakub Novotny